Synvisc to get November panel review:
This article was originally published in Clinica
Executive Summary
The FDA says Biomatrix' osteoarthritis product, Synvisc, will be reviewed by its Orthopedic and Rehabilitation Devices Advisory Panel on November 20th. Synvisc is a hylan polymer.